ARCT

Arcturus Therapeutics Holdings Inc

26.265
-0.905 (-3.33%)

Arcturus Therapeutics Holdings Inc. (ARCT) Fundamentals

Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in the segment of research and development of medical applications for nucleic acid-focused technology. The product pipeline of the company includes LUNAR-OTC, LUNAR-CF, and LUNAR-COV19.
SHARE INFORMATION
Market CapUS$ 721,715,379
Shares Outstanding26,562,951
Float22,900,000
Percent Float86.21%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per ShareUS$ 0.00
Latest Fiscal RevenueUS$ 80,285,000
Latest Fiscal EPSUS$ 1.91
Latest Fiscal Date2023-03-31
DIVIDENDS
Dividend (3 Years)US$ 0.00
Dividend (5 Years)US$ 0.00
Ex Dividend Date-
Dividend RateUS$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions336
Institutional Holdings Date2023-03-31
Institutional Bought Previous 3 Months4,623,662
Institutional Holdings Percent176.7%
Institutional Sold Previous 3 Months2,144,174
Insider Holdings Date2023-03-31
Insider Bought Previous 3 Months-
Insider Holdings Percent2.2
Insider Sold Previous 3 Months5,000
Insider Shares Owned589,448
TRADING INFO
52 Week HighUS$ 33.80
52 Week LowUS$ 11.70
52 Week High ChangeUS$ 63.58
21 Day Moving AverageUS$ 27.9805
21 Day Extended Moving AverageUS$ 27.6609
50 Day Moving AverageUS$ 25.2344
50 Day Extended Moving AverageUS$ 25.5944
200 Day Moving AverageUS$ 19.2589
200 Day Extended Moving AverageUS$ 21.7839
10 Day Average Volume386,441
20 Day Average Volume457,695
30 Day Average Volume445,275
50 Day Average Volume575,973
Alpha0.044094
Beta2.6078
Standard Deviation0.320748
R20.191105
7 Day Price ChangeUS$ 0.44
7 Day Percent Change1.65%
21 Day Price ChangeUS$ 0.07
21 Day Percent Change0.26%
30 Day Price ChangeUS$ 0.52
30 Day Percent Change1.95%
Month to Date Price ChangeUS$ 0.55
Month to Date Percent Change2.07%
Quarter to Date Price ChangeUS$ 3.20
Quarter to Date Percent Change13.35%
180 Day Price ChangeUS$ 10.69
180 Day Percent Change64.87%
200 Day Price ChangeUS$ 4.21
200 Day Percent Change18.34%
Year to Date Price ChangeUS$ 10.21
Year to Date Percent Change60.2%

Arcturus Therapeutics Holdings Inc. (ARCT) Key Ratios

PROFITABILITY
EBIT Margin6.5%
EBITDA Margin6.5%
Pre-Tax Profit Margin-118.4%
Profit Margin Count0.63%
Gross Margin77.8%
Profit Margin TOT0.63%
INCOME STATEMENTS
RevenueUS$ 80,285,000
Revenue Per ShareUS$ 3.0224
Revenue (3 Years)US$ 114.70
Revenue (5 Years)US$ 86.67
FINANCIAL STRENGTH
Price to Tangible Book2.70
Total Debt To Equity0.30
Int Coverage5.00
Current Ratio3.20
Leverage Ratio1.70
Quick Ratio3.10
Long Term Debt To Capital0.10
VALUATION MEASURES
PE Ratio80.20
Enterprise ValueUS$ 451,655,366
Price to Sales3.64
Price to Free Cash1.10
PE High Last 5 Years-2.00
Price To Book2.70
Price To Cash Flow1.10
PE Low Last 5 Years-65.20
Price to Tangible Book2.70
MANAGEMENT EFFECTIVENESS
Receivables Turnover67.20
Invoice Turnover0.00
Assets Turnover0.50
Return Assets2.22
Return on Equity3.75
Return on Capital3.66

Arcturus Therapeutics Holdings Inc. (ARCT) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
Auditor-
CEOJoseph E Payne
Employees177
Last Audit-
CIK0001768224
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address10628 Science Center Drive,Suite 250
Suite 250
San Diego, CA 92121
Websitehttps://www.arcturusrx.com
Facsimile-
Telephone+1 858 900-2660
EmailIR@ArcturusRx.com
Your Recent History
NASDAQ
ARCT
Arcturus T..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now
NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 | help@advfn.com

V: au D: 20230530 17:51:56